Integrated Kidney Care of the Midwest, LLC
KCE Located In: Illinois and Indiana
Participant Groups and Providers
ILLIANA NEPHROLOGY ASSOCIATES LTD
ABD NOGHNOGH
ILLINOIS KIDNEY CARE PLLC
DANIEL ROSEMAN
INTERNAL MEDICINE NEPHROLOGY, INC.
KUMAR GAURAV
LORI WILEY
MANISH GERA
MEGAN TEMPLES
RAJ JEEVAN
KIDNEY AND HYPERTENSION CENTER OF WABASH VALLEY LLC
KUMAR GAURAV
LORENZO GALLON M.D
LORENZO GALLON
NEPHROLOGY SPECIALISTS, P.C.
JONATHAN SILVERMAN
MAHER AJAM
MOHAMMAD SALEH
MOHAMMAD TINAWI
MUHAMMAD SOUQIYYEH
NAVJYOT BHOGAL
PREETI GURNANI
RAIED ABDULLAH
SANJEEV RASTOGI
SHAHABUL ARFEEN
NORTHWEST MEDICAL ASSOCIATES OF CHICAGO LLC
APARNA NATARAJAN
AROUNA SENTHILKUMAR
IZABELLA GURAU
OGBONNAYA ANEZIOKORO
RENAL PHYSICIANS INC
AUGUSTUS EDUAFO
Preferred Groups and Providers
VILLAGEHEALTH DM LLC
Governing Body Designees
Clinical and Administrative Leadership
Heather Long
Primary Contact & Administrative Leader
Senior Director, DaVita IKC
Sanjeev Rastogi
KCE Clinical Leader
Nephrology Specialists
Quality Measures
Information for the following performance measures will be available by February 1st, 2024.
- The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
- The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
- Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.
Shared Savings and Losses
Information for the following performance measures will be available by February 1st, 2024.
- Total amount of Shared Savings or Shared Losses per Performance Year
- Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
- Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year
For a full list of facilities and joint ventures, please click here.
For more information on CKCC, click here.